NuvaRing Lawsuits Filed

Merck, the manufacturer of the NuvaRing hormonal contraceptive, is defending itself from over 1,000 plaintiffs who allege that their device is to blame for diagnoses of stroke, blood clot, deep vein thrombosis and pulmonary embolism. More »

yaz-yasmin-fda-panel-review
POSTED BY
Claire Choo

The FDA recently considered whether or not to keep Yaz and Yasmin type birth control pills on the market. While the panel ultimately decided that the drugs should stay on the market, it was later reported that four of those panel members who voted in favor of keeping the contraceptives on the market (in a 15-11 vote) had financial ties to manufacturer, Bayer. More »

stronger-yaz-warning-labels
POSTED BY
Claire Choo

The Food and Drug Administration recently voted to strengthen the warning labels for Yaz and Yasmin. This came after the birth control medications narrowly won a vote by the FDA on whether or not to allow the drugs to stay on market at all. This is just the latest in a longstanding debate over the safety of the drugs’ primary ingredient, drospirenone. More »